Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
US$ 24,500.00
... Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, ... marketing tactics, and new products in R&D. Market Segmentation Analysis Comprehensive market segmentation analysis, including review of the market ... emerging clinical chemistry and immunodiagnostic tests. Review of current ...
June 2018
1115 pages
Zimmer: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Zimmer, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
Aesculap: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Aesculap, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
22 pages
Biomet: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Biomet, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Wright Medical: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
ConMed: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of ConMed, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Medtronic: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Medtronic, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Smith & Nephew: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
37 pages
Stryker: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Stryker, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Synthes: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Synthes, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
Orthopedic Devices: Accelerated Rate of Change and Regulatory Uncertainty--Performance, Capabilities, Goals and Strategies of Leading Suppliers
US$ 3,850.00
... U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation ... , etc. The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants ...
June 2018
325 pages
